Uysal, who studied for his doctorate in Molecular Biology and Biochemistry at the University of Chicago after his education at MIT (Massachusetts Institute of Technology), continued his research at Harvard University for six years in the capacity of a postdoctoral researcher. Having worked in the same period on the "production of synthetic antibodies", which is a technology that has a scope of applications on various diseases and cancer in particular, Uysal pioneered studies in the field of protein production and purification by recombinant means, which forms the basis of vaccine, protein and pharmaceutical group protein-based drug studies.